Health Insurance Innovations Inc (NASDAQ:HIIQ)‘s stock had its “buy” rating reaffirmed by investment analysts at Canaccord Genuity in a research note issued on Monday. They presently have a $39.00 price objective on the financial services provider’s stock. Canaccord Genuity’s price objective would suggest a potential upside of 85.05% from the company’s current price.

The analysts wrote, “Date and time of first dissemination: October 16, 2017, 09:40 ET Date and time of production: October 16, 2017, 09:40 ET Target Price / Valuation Methodology: Health Insurance Innovations – HIIQ Our $39 PT is based on an 12.6x target multiple on our 2018 adj. EBITDA estimate. Our target multiple is a 25% discount to a peer group of non-provider health and insurance related technology companies.””

Several other equities analysts have also recently issued reports on HIIQ. ValuEngine cut Health Insurance Innovations from a “buy” rating to a “hold” rating in a report on Monday, August 14th. Zacks Investment Research upgraded Health Insurance Innovations from a “hold” rating to a “buy” rating and set a $33.00 price target on the stock in a report on Friday, August 4th. Craig Hallum reiterated a “buy” rating and issued a $38.00 price target (up previously from $28.00) on shares of Health Insurance Innovations in a report on Thursday, August 3rd. TheStreet cut Health Insurance Innovations from a “b-” rating to a “c” rating in a report on Thursday, September 28th. Finally, Raymond James Financial, Inc. reiterated a “market perform” rating on shares of Health Insurance Innovations in a report on Monday, June 26th. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. Health Insurance Innovations has a consensus rating of “Buy” and a consensus target price of $31.33.

Shares of Health Insurance Innovations (NASDAQ HIIQ) traded up 11.64% during midday trading on Monday, reaching $21.10. 3,212,335 shares of the company’s stock were exchanged. The company has a market capitalization of $263.10 million, a PE ratio of 17.07 and a beta of 0.53. The firm has a 50-day moving average of $22.88 and a 200-day moving average of $23.20. Health Insurance Innovations has a 1-year low of $4.00 and a 1-year high of $37.38.

Health Insurance Innovations (NASDAQ:HIIQ) last posted its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.13. The business had revenue of $61.80 million for the quarter, compared to analysts’ expectations of $53.69 million. Health Insurance Innovations had a return on equity of 23.82% and a net margin of 11.25%. The business’s quarterly revenue was up 38.9% on a year-over-year basis. Equities analysts expect that Health Insurance Innovations will post $1.53 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/16/health-insurance-innovations-inc-hiiq-given-buy-rating-at-canaccord-genuity.html.

In other Health Insurance Innovations news, insider Sheldon Wang sold 4,530 shares of the firm’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $32.73, for a total transaction of $148,266.90. Following the transaction, the insider now owns 224,894 shares in the company, valued at $7,360,780.62. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Bruce Telkamp sold 15,000 shares of the firm’s stock in a transaction dated Wednesday, August 2nd. The stock was sold at an average price of $26.27, for a total value of $394,050.00. Following the transaction, the chief executive officer now owns 29,201 shares in the company, valued at approximately $767,110.27. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 170,077 shares of company stock worth $4,959,558. Company insiders own 30.00% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the business. Morgan Stanley boosted its holdings in Health Insurance Innovations by 240.2% during the first quarter. Morgan Stanley now owns 70,397 shares of the financial services provider’s stock worth $1,127,000 after buying an additional 49,703 shares during the last quarter. Argent Capital Management LLC boosted its holdings in Health Insurance Innovations by 34.5% during the second quarter. Argent Capital Management LLC now owns 175,975 shares of the financial services provider’s stock worth $4,135,000 after buying an additional 45,100 shares during the last quarter. Tudor Investment Corp ET AL bought a new position in Health Insurance Innovations during the first quarter worth about $648,000. Granite Point Capital Management L.P. boosted its holdings in Health Insurance Innovations by 8.8% during the second quarter. Granite Point Capital Management L.P. now owns 87,900 shares of the financial services provider’s stock worth $2,066,000 after buying an additional 7,100 shares during the last quarter. Finally, Capital World Investors bought a new position in Health Insurance Innovations during the second quarter worth about $11,680,000. Hedge funds and other institutional investors own 66.22% of the company’s stock.

Health Insurance Innovations Company Profile

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Analyst Recommendations for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc and related companies with MarketBeat.com's FREE daily email newsletter.